Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TWLO vs GSK✓SelectedUSD · GSKTWLO vs GSK performance historyLatest closeAs of-2.65%11/17
Stock and ETF performance explorer

TWLO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+574.3%
GSK return
+87.7%
Excess return
+486.6%
Maximum drawdown
-90.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%-2.3%-0.3%-2.1%
7D-9.4%-3.0%-6.4%-8.7%
30D-20.6%+0.4%-20.9%-20.8%
3M-15.1%-1.2%-13.9%-15.1%
6M-2.1%+0.9%-3.0%-3.1%
YTD+36.5%+4.0%+32.5%+32.6%
1Y+61.5%+7.3%+54.2%+55.4%
3Y+207.6%+57.1%+150.5%+152.9%
5Y-35.9%+43.0%-78.8%-46.3%
10Y+451.3%+103.1%+348.3%+238.9%
All+574.3%+87.7%+486.6%+358.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling